Eli Lilly’s $2.4 Billion Pending Acquisition of DICE THerapeutics

Fenwick & West LLP represented DICE Therapeutics, Inc. in the transaction, while Kirkland & Ellis represented Eli Lilly and Company.Eli Lilly and Company (NYSE: LLY) announced…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now